Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $56.45 ($2.3M) on 2018-09-19, disclosed to the SEC on 2018-09-21.
Scheduled sale ($2.3M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.45 | 11,408 | $644K | 28.1% |
| 2 | $56.71 | 710 | $40K | 1.8% |
| 3 | $57.48 | 208 | $12K | 0.5% |
| 4 | $57.50 | 7,492 | $431K | 18.8% |
| 5 | $57.36 | 1,291 | $74K | 3.2% |
| 6 | $57.64 | 9 |
| $519 |
| 0.0% |
| 7 | $58.84 | 17,609 | $1.0M | 45.2% |
| 8 | $58.88 | 909 | $54K | 2.3% |
| Total | $57.81 avg | 39,636 | $2.3M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |